Accéder au contenu
Merck

Convergent Evolution in Breadth of Two VH6-1-Encoded Influenza Antibody Clonotypes from a Single Donor.

Cell host & microbe (2020-07-04)
Nicholas C Wu, Sarah F Andrews, Julie E Raab, Sarah O'Connell, Chaim A Schramm, Xintao Ding, Michael J Chambers, Kwanyee Leung, Lingshu Wang, Yi Zhang, John R Mascola, Daniel C Douek, Julie E Ledgerwood, Adrian B McDermott, Ian A Wilson
RÉSUMÉ

Understanding how broadly neutralizing antibodies (bnAbs) to influenza hemagglutinin (HA) naturally develop in humans is critical to the design of universal influenza vaccines. Several classes of bnAbs directed to the conserved HA stem were found in multiple individuals, including one encoded by heavy-chain variable domain VH6-1. We describe two genetically similar VH6-1 bnAb clonotypes from the same individual that exhibit different developmental paths toward broad neutralization activity. One clonotype evolved from a germline precursor recognizing influenza group 1 subtypes to gain breadth to group 2 subtypes. The other clonotype recognized group 2 subtypes and developed binding to group 1 subtypes through somatic hypermutation. Crystal structures reveal that the specificity differences are primarily mediated by complementarity-determining region H3 (CDR H3). Thus, while VH6-1 provides a framework for development of HA stem-directed bnAbs, sequence differences in CDR H3 junctional regions during VDJ recombination can alter reactivity and evolutionary pathways toward increased breadth.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Chlorure de sodium, ACS reagent, ≥99.0%
Sigma-Aldrich
Acide chlorhydrique, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
Benzocaine, ≥99% (HPLC)
Sigma-Aldrich
Azoture de sodium, ReagentPlus®, ≥99.5%